awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37590339-DA982F4B-D8B0-4628-8411-5A6661D56B38
Q37590339-DA982F4B-D8B0-4628-8411-5A6661D56B38
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37590339-DA982F4B-D8B0-4628-8411-5A6661D56B38
NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies.
P2860
Q37590339-DA982F4B-D8B0-4628-8411-5A6661D56B38
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37590339-DA982F4B-D8B0-4628-8411-5A6661D56B38
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ce4eae25a39698a82c04ee445c8f82d46d27f749
P2860
A phase I/II study of erlotinib in combination with the anti-insulin-like growth factor-1 receptor monoclonal antibody IMC-A12 (cixutumumab) in patients with advanced non-small cell lung cancer